Search results for "AMyloid"

showing 10 items of 494 documents

Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative da…

2001

In the aging dog brain lesions develop spontaneously. They share some morphological characteristics with those of Alzheimer 's disease in man. Diffuse and primitive plaques are well known, whereas neuritic plaques rarely develop. Neurofibrillary tangles have not been seen in the canine. The aim of the present investigation was to study major age-related changes of the dog's brain using paraffin sections with respect to cross-immunoreactivity of tau, A beta protein and other immunoreactive components including hydroxynonenal protein, which is a marker for oxidative damage. The occurrence of neurofibrillary tangles and of the protein tau therein was studied in serial brain sections of two dog…

Pathologymedicine.medical_specialtyAgingAmyloidmedicine.drug_classTau proteinModels NeurologicalNerve Tissue ProteinsPlaque AmyloidMonoclonal antibodymedicine.disease_causeDogsAlzheimer DiseaseInternal MedicinemedicineAnimalsHumansSenile plaquesDog DiseasesAldehydesbiologyChemistryBrainNeurofibrillary Tanglesmedicine.diseaseImmunohistochemistryOxidative StressPolyclonal antibodiesbiology.proteinImmunohistochemistryAlzheimer's diseaseOxidative stressAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
researchProduct

Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease

2015

Neurofibrillary tangles (aggregates of cytoskeletal Tau protein) and senile plaques (aggregates mainly formed by amyloid β peptide) are two landmark lesions in Alzheimer׳s disease. Some researchers have proposed tangles, whereas others have proposed plaques, as primary lesions. For a long time, these were thought of as independent mechanisms. However, experimental evidence suggests that both lesions are intimately related. We review here some molecular pathways linking amyloid β and Tau toxicities involving, among others, glycogen synthase kinase 3β, p38, Pin1, cyclin-dependent kinase 5, and regulator of calcineurin 1. Understanding amyloid β and Tau toxicities as part of a common pathophys…

Pathologymedicine.medical_specialtyAmyloid beta-PeptidesbiologyChemistryKinaseNeurodegenerationTau proteinBACE1-AStau Proteinsmedicine.diseaseProtein Aggregation PathologicalBiochemistryBiochemistry of Alzheimer's diseaseAlzheimer DiseaseGSK-3Physiology (medical)mental disordersmedicinebiology.proteinCancer researchPIN1HumansSenile plaquesPhosphorylationFree Radical Biology and Medicine
researchProduct

Perikollagene Amyloidablagerungen in Haut und inneren Organen bei Sklerodermie

1969

Bei 18 Sklerodermie-Patienten konnte in 2 Fallen polarisationsoptisch in der Haut perikollagenes Amyloid nachgewiesen werden, bei 1 Obduktionsfall dieser Beobachtungsreihe gleicherweise in einigen Innenorganen, jedoch nicht in der Haut.

Pathologymedicine.medical_specialtyAmyloidbusiness.industryGeneral Medicinemedicine.diseaseMolecular medicineSclerodermaHuman geneticsDrug DiscoveryMolecular MedicineMedicinebusinessGenetics (clinical)Klinische Wochenschrift
researchProduct

Is antioxidant therapy effective to treat alzheimer's disease?

2011

Alzheimer’s disease (AD) is a neurodegenerative process associated with oxidative stress. In the past, it was claimed that all neuronal lesions involved in the onset and progression of AD were related to oxidative stress. Today, we know that intracellular amyloid beta (Ab) could play a central role in the pathophysiology of the disease. Ab binds to heme groups in mitochondrial membranes causing electron transport chain impairment and loss of respiratory function. The experimental evidence of such oxidative stress leads to the basis for treatment of AD with antioxidants. Many clinical trials have been developed to clarify whether antioxidants are beneficial in AD treatment. However, the resu…

Pathologymedicine.medical_specialtyAntioxidantbiologyAmyloid betamedicine.medical_treatmentDiseasemedicine.disease_causeBioinformaticsPathophysiologychemistry.chemical_compoundchemistrybiology.proteinmedicineRespiratory functionHemeIntracellularOxidative stressFree Radicals and Antioxidants
researchProduct

Protection of Flupirtine on β-Amyloid-Induced Apoptosis in Neuronal Cells In Vitro: Prevention of Amyloid-Induced Glutathione Depletion

2002

Effective drugs are not available to protect against beta-amyloid peptide (A beta)-induced neurotoxicity. Cortical neurons from rat embryos were treated with the toxic fragment A beta25-35 at 1 microM in the presence or absence of flupirtine, a triaminopyridine, successfully applied clinically as a nonopiate analgesic drug. Five days later 1 microM A beta25-35 caused reduction of cell viability to 31.1%. Preincubation of cells with flupirtine (1 or 5 microg/ml) resulted in a significant increase of the percentage of viable cells (74.6 and 65.4%, respectively). During incubation with A beta25-35 the neurons undergo apoptosis as determined by appearance of the characteristic stepladder-like D…

Pathologymedicine.medical_specialtyCell SurvivalAminopyridinesApoptosisPharmacologymedicine.disease_causeBiochemistryAntioxidantsCellular and Molecular NeurosciencemedicineAnimalsViability assaySenile plaquesRats WistarCerebral CortexNeuronsAmyloid beta-PeptidesChemistryNeurotoxicitymedicine.diseaseGlutathionePeptide FragmentsRatsOxidative StressNeuroprotective AgentsApoptosisCell cultureDNA fragmentationFlupirtineOxidative stressmedicine.drugJournal of Neurochemistry
researchProduct

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus

2012

Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer's disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1(M146L)/APP(751SL) mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification…

Pathologymedicine.medical_specialtyNeuriteClinical NeurologyHippocampusMice TransgenicPlaque AmyloidAmyloid plaquesBiologyHippocampal formationHippocampusDystrophic neuritesPathology and Forensic MedicineAmyloid beta-Protein PrecursorMiceCellular and Molecular NeuroscienceAlzheimer DiseaseAutophagyNeuritesmedicineElectron microscopyLC3AnimalsSenile plaquesMicroscopy ImmunoelectronNeuronsSynaptosomeOriginal PaperPS1/APP transgenic miceCytoplasmic VesiclesAutophagymedicine.diseaseAxonsDisease Models AnimalPresynaptic terminalsAxoplasmic transportNeurology (clinical)Alzheimer's disease
researchProduct

Alzheimer's disease: Amyloid deposits in the cerebellar cortex

1989

Pathologymedicine.medical_specialtyNeurologyAmyloidbusiness.industryGeneral NeuroscienceDiseasePsychiatry and Mental healthNeurologyCerebellar cortexmedicineNeurology (clinical)Senile plaquesbusinessBiological PsychiatryJournal of Neural Transmission - Parkinson's Disease and Dementia Section
researchProduct

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

2016

Background: The treatment and diagnosis of Alzheimer’s Disease (AD) are two of the most urgent goals for research around the world. The cognitive decline is generally associated with the elevated levels of extracellular senile plaques, intracellular neurofibril- lary tangles (NFTs), and with a progressive shutdown of the cholinergic basal forebrain neurons transmission. Even if several key targets are under fervent investigation in the cure of AD, till now, the only approved therapeutic strategy is the treatment of symptoms by using cholinesterases inhibitors. It has been demonstrated that both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes are not only responsible of…

Pathologymedicine.medical_specialtyTau proteinDisease010402 general chemistry01 natural scienceschemistry.chemical_compoundAlzheimer DiseaseHeterocyclic CompoundsDrug DiscoverymedicineAnimalsHumansSenile plaquesCognitive declineButyrylcholinesterasePharmacologybiologyMolecular Structure010405 organic chemistryChemistryAcetylcholinesterase0104 chemical sciencesbiology.proteinCholinergicNeuroscienceAmyloid precursor protein secretaseAlzheimer’s disease amyloid-peptide secretase acetylcholinesterase tau protein heterocycles
researchProduct

Amyloidose des Knochens und der Weichteile nach einem Plasmozytom

1992

Pathologymedicine.medical_specialtyTechnetium compoundsbusiness.industryAmyloidosisDiphosphonateschemistry.chemical_elementSoft tissueTechnetiummedicine.diseaseTomography x ray computedchemistryRadiological weaponmedicinePlasmacytomaRadiology Nuclear Medicine and imagingbusinessRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis

2021

The involvement of β-amyloid (Aβ) in the pathogenesis of amyotrophic lateral sclerosis (ALS) has been widely discussed and its role in the disease is still a matter of debate. Aβ accumulates in the cortex and the anterior horn neurons of ALS patients and seems to affect their survival. To clarify the role of cerebrospinal fluid (CSF) Aβ 1–42 and Aβ 42/40 ratios as a potential prognostic biomarker for ALS, we performed a retrospective observational study on a cohort of ALS patients who underwent a lumbar puncture at the time of the diagnosis. CSF Aβ 1–40 and Aβ 1–42 ratios were detected by chemiluminescence immunoassay and their values were correlated with clinical features. We found a signi…

Pathologymedicine.medical_specialtybeta amyloidArticlelcsh:RC321-571Pathogenesis03 medical and health sciences0302 clinical medicineCerebrospinal fluidmedicineAmyotrophic lateral sclerosislcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesMini–Mental State Examinationmedicine.diagnostic_testLumbar puncturebusiness.industryGeneral Neurosciencebiomarker.Retrospective cohort studymedicine.diseaseCortex (botany)Biomarker (medicine)biomarkerALSbusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct